GB0807579D0 - Vaccine composition and method - Google Patents

Vaccine composition and method

Info

Publication number
GB0807579D0
GB0807579D0 GB0807579A GB0807579A GB0807579D0 GB 0807579 D0 GB0807579 D0 GB 0807579D0 GB 0807579 A GB0807579 A GB 0807579A GB 0807579 A GB0807579 A GB 0807579A GB 0807579 D0 GB0807579 D0 GB 0807579D0
Authority
GB
United Kingdom
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0807579A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thrombosis Research Institute
Original Assignee
Thrombosis Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrombosis Research Institute filed Critical Thrombosis Research Institute
Priority to GB0807579A priority Critical patent/GB0807579D0/en
Publication of GB0807579D0 publication Critical patent/GB0807579D0/en
Priority to JP2011503506A priority patent/JP5654446B2/en
Priority to PCT/GB2009/050366 priority patent/WO2009125231A2/en
Priority to US12/937,235 priority patent/US8435538B2/en
Priority to CA2758213A priority patent/CA2758213C/en
Priority to EP09730769.8A priority patent/EP2281007B1/en
Ceased legal-status Critical Current

Links

GB0807579A 2008-04-10 2008-04-25 Vaccine composition and method Ceased GB0807579D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0807579A GB0807579D0 (en) 2008-04-25 2008-04-25 Vaccine composition and method
JP2011503506A JP5654446B2 (en) 2008-04-10 2009-04-14 Anti-atheroma vaccine
PCT/GB2009/050366 WO2009125231A2 (en) 2008-04-10 2009-04-14 Anti-atheroma vaccine
US12/937,235 US8435538B2 (en) 2008-04-10 2009-04-14 Anti-atheroma vaccine
CA2758213A CA2758213C (en) 2008-04-10 2009-04-14 Anti-atheroma vaccine
EP09730769.8A EP2281007B1 (en) 2008-04-10 2009-04-14 Anti-atheroma vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0807579A GB0807579D0 (en) 2008-04-25 2008-04-25 Vaccine composition and method

Publications (1)

Publication Number Publication Date
GB0807579D0 true GB0807579D0 (en) 2008-06-04

Family

ID=39522567

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0807579A Ceased GB0807579D0 (en) 2008-04-10 2008-04-25 Vaccine composition and method

Country Status (1)

Country Link
GB (1) GB0807579D0 (en)

Similar Documents

Publication Publication Date Title
IL210153A0 (en) Nutrigenomics methods and compositions
GB0815872D0 (en) Novel method and compositions
EP2377154A4 (en) Via structure and method thereof
EP2308884A4 (en) Method for producing -hetero-substituted alkylhalohydrosilane and use thereof
IL212822A0 (en) Anti-cxcr1 compositions and methods
GB0819530D0 (en) Methods and compositions
IL210559A0 (en) Novel compositions and methods
EP2285405A4 (en) Vaccine compositions and methods
GB0709781D0 (en) Composition and method
IL210588A0 (en) Novel compositions and methods
GB0912468D0 (en) Composition and method
GB0724967D0 (en) Composition and method
GB0903299D0 (en) Composition and methods
GB0817585D0 (en) Novel compositions and methods
GB0901667D0 (en) Composition and method
GB0811250D0 (en) Methods and compositions
GB0801122D0 (en) Vaccine composition
GB0807579D0 (en) Vaccine composition and method
GB0807102D0 (en) Process and composition
GB0817553D0 (en) Composition and method
GB0816946D0 (en) Composition and method
GB0806334D0 (en) Method and composition
GB0802079D0 (en) Method and compositions
GB0908956D0 (en) Method and composition
GB0906693D0 (en) Composition and method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)